2022
DOI: 10.1016/j.matpr.2020.08.002
|View full text |Cite
|
Sign up to set email alerts
|

QSAR and docking molecular models to predict anti-cancer activity on a series of azacalix [2] arene [2] pyrimidine derivatives as anticancer agents

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 18 publications
0
1
0
Order By: Relevance
“…A large quantum of Computational work has been carried out on many Pyrimidine derivatives as evident from many research articles in search of lead molecules for anticancer activity. [22][23][24][25][26] As apparent from different observations, treatment of PCa is complex and necessitates efforts to develop more target specific therapy that can be used to overcome drug-resistant in CRPC patients. Hencein the present investigation we have explored trifluoromethyl-substituted pyrimidine scaffold for prostate anti-cancer activity using molecular modelling studies.…”
Section: Introductionmentioning
confidence: 99%
“…A large quantum of Computational work has been carried out on many Pyrimidine derivatives as evident from many research articles in search of lead molecules for anticancer activity. [22][23][24][25][26] As apparent from different observations, treatment of PCa is complex and necessitates efforts to develop more target specific therapy that can be used to overcome drug-resistant in CRPC patients. Hencein the present investigation we have explored trifluoromethyl-substituted pyrimidine scaffold for prostate anti-cancer activity using molecular modelling studies.…”
Section: Introductionmentioning
confidence: 99%